These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 35924233)
1. Role of Vγ9vδ2 T lymphocytes in infectious diseases. Gay L; Mezouar S; Cano C; Frohna P; Madakamutil L; Mège JL; Olive D Front Immunol; 2022; 13():928441. PubMed ID: 35924233 [TBL] [Abstract][Full Text] [Related]
2. BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against Gay L; Mezouar S; Cano C; Foucher E; Gabriac M; Fullana M; Madakamutil L; Mège JL; Olive D Front Immunol; 2022; 13():915244. PubMed ID: 35833118 [TBL] [Abstract][Full Text] [Related]
3. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells. Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935 [TBL] [Abstract][Full Text] [Related]
4. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing. Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411 [TBL] [Abstract][Full Text] [Related]
5. The Armadillo ( Fichtner AS; Karunakaran MM; Starick L; Truman RW; Herrmann T Front Immunol; 2018; 9():265. PubMed ID: 29527206 [TBL] [Abstract][Full Text] [Related]
6. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins. Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807 [TBL] [Abstract][Full Text] [Related]
7. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells. Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084 [TBL] [Abstract][Full Text] [Related]
9. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation. Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636 [TBL] [Abstract][Full Text] [Related]
10. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation. Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997 [TBL] [Abstract][Full Text] [Related]
11. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. Sandstrom A; Peigné CM; Léger A; Crooks JE; Konczak F; Gesnel MC; Breathnach R; Bonneville M; Scotet E; Adams EJ Immunity; 2014 Apr; 40(4):490-500. PubMed ID: 24703779 [TBL] [Abstract][Full Text] [Related]
12. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells. Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP Science; 2020 Feb; 367(6478):. PubMed ID: 31919129 [TBL] [Abstract][Full Text] [Related]
13. Immune recognition of phosphoantigen-butyrophilin molecular complexes by γδ T cells. Uldrich AP; Rigau M; Godfrey DI Immunol Rev; 2020 Nov; 298(1):74-83. PubMed ID: 33017054 [TBL] [Abstract][Full Text] [Related]
14. Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killing. Wu Z; Lamao Q; Gu M; Jin X; Liu Y; Tian F; Yu Y; Yuan P; Gao S; Fulford TS; Uldrich AP; Wong CC; Wei W Cell Mol Immunol; 2024 Apr; 21(4):362-373. PubMed ID: 38374404 [TBL] [Abstract][Full Text] [Related]
16. [Butyrophilin 3A1 (BTN3A1) enhances activation and proliferation of human peripheral blood Vγ9Vδ2 T cells induced by MTB-HAg]. Tang J; Sun J; Zha C; Chang J; Hu K; Fang Q; Chen Y; Chen J; Li B Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):680-686. PubMed ID: 32958123 [TBL] [Abstract][Full Text] [Related]
17. Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance. Nussbaumer O; Thurnher M Cells; 2020 Mar; 9(3):. PubMed ID: 32235722 [TBL] [Abstract][Full Text] [Related]
18. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells. Riganti C; Castella B; Massaia M Front Immunol; 2018; 9():1246. PubMed ID: 29937767 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of BTN3A1 on CD14 Zhou J; Zhang J; Tao L; Peng K; Zhang Q; Yan K; Luan J; Pan J; Su X; Sun J; Zhang Z; Shen L Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2117523119. PubMed ID: 36288286 [TBL] [Abstract][Full Text] [Related]